{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6776, 
        6782
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6783, 
        6792
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7030, 
        7044
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6492, 
        6515
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6691, 
        6718
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6724, 
        6728
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7141, 
        7145
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7158, 
        7162
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6890, 
        6909
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6976, 
        6995
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7206, 
        7216
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7222, 
        7241
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7261, 
        7271
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7277, 
        7296
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1136, 
        1165
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4207, 
        4242
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7110, 
        7136
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7006, 
        7018
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6767, 
        6775
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7019, 
        7029
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6729, 
        6735
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7146, 
        7152
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7163, 
        7169
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6720, 
        6722
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6886, 
        6888
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7138, 
        7140
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7203, 
        7205
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7258, 
        7260
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 4^9999^MOH|PIMS|CCO|201605030404|B22C20480958556CE48E66758EEB5AF6CD57AFAB|ORU^R01|999999999999|P|2.5|||||||\nPID|||H999999^^^^CMR^HOSPITAL 4&9999&MOH~H999999^^^^MRN^HOSPITAL 4&9999&MOH~9999999999&TK&ON^^^^JHN||XXXXXX^XXXXX^XXXXX||99999999|F|XXXXX^XXXXX^XXXXX||99 XXXXXXXX XXXXXX^^XXXXXXXXX^XX^X9X 9X9^999|ON|9999999999^TK^ON||E|M|ANG|3125119036^TK^ON||||||||||||N||\nOBR|1||S16:4782^LIS|11529-5^Surgical Pathology Study Report^LN^P^Pathology^L|||201604181154|||52663^XXXXXX^XXXXX XXXXX^^^^||||201604181315||999999^XXXXXX^XXXXX XXXXX^^^^||||N||201604190813|||F|||||||99999^XXXXXXX^XXXXXX^^^^|||||||||||||\nOBX|1|FT|22638-1^Path report.comments^LN||||||||C|||||||\n\n\n\n\n\n\n\nPath report.addendum spec\n\n***********************************************************\n         This is an addended report       \n***********************************************************\nThe biomarkers reported at HOSPITAL 1 were as follows:\nestrogen receptor: positive\nprogesterone receptor: positive\nHER2/neu overexpression: negative\nFull external consult report available upon request through\nthe Pathology office (ext. 2518/2880).\n\n\nPath report.gross description\n\nIt is our practice that all surgical specimens undergo a minimum fixation period of 24\nhours.\nA.  The specimen container is labelled `left breast lumpectomy'. The specimen consists of\n   a lumpectomy overall measuring 7.5 cm medial to lateral, 3.2 cm superior to inferior\n   and 7.5 cm anterior to posterior. Sutures are present to orient the specimen. The\n   specimen is inked as follows:\n     The superior resection margin is inked blue.\n     The inferior resection margin is inked green.\n     The deep resection margin is inked black.\n     The anterior resection margin is inked yellow.\n     The medial resection margin is inked orange.\n     The lateral resection margin is inked red.\n   The specimen is serially sectioned and allowed to fix. The cold ischemic time is\n   1 hour 45 minutes. Localizing wires are present to indicate an area of concern. A\n   radiograph accompanies the specimen. Opening of the specimen reveals a firm, pale tan\n   lesion with hemorrhagic areas. Overall this lesion measure approximately 1.2 cm x 1.2\n   cm x approximately 1.0 cm. This lesion has irregular borders and measures 0.8 cm from\n   the inferior resection margin which is the closest resection margin, 1.3 cm from the\n   medial resection margin, 1.4 cm from the superior resection margin, approximately 2.0\n   cm from the anterior resection margin, approximately 3.5 cm from the lateral resection\n   margin, and approximately 5.0 cm from the deep resection margin. Areas of\n   calcification are noted on the radiograph surrounding the described lesion.\n   Representative sections are submitted as follows:\n   'A1'   lesion and closest inferior resection margin\n   'A2'   adjacent closest medial resection margin\n   'A3'   adjacent closest superior resection margin\n   'A4'   tumor including inferior resection margin\n   'A5'   adjacent medial margin\n   'A6'   closest lateral resection margin\n   'A7'   anterior aspect of lesion\n   'A8'   anterior resection margin\n   'A9-A10' area of tissue immediately posterior to the lesion, possibly including\n        visible calcifications on radiograph\n   'A11'   possible area of calcification lateral to the described lesion\n   'A12'   possible area of calcifications anterior to the described lesion\n   'A13-A14' fibrous areas of tissue posterior to the described lesion\n   'A15'   posterior resection margin.\nB.  The specimen container is labelled `#1 sentinel lymph node #1 hot and blue'. The\n   specimen consists of a lobular piece of adipose tissue measuring up to 1.3 cm in\n   greatest dimension. The specimen is checked for nodes. One possible node is grossly\n   identified and submitted in two cassettes.\nC.  The specimen container is labelled `a #2 sentinel lymph node #2 hot'. The specimen\n   consists of a lobular piece of yellow adipose tissue measuring up to 1.2 cm in\n   greatest dimension. The specimen is checked for nodes. One possible node is grossly\n   identified and submitted in cassette 'C1'. The remainder of the tissue is submitted\n   in cassette 'C2'. All tissue is submitted.\n\n\nPath report.microscopic observation\n\nEXAM: Breast Invasive Carcinoma : 1       \nSpecimen\n Procedure: Excision with wire-guided localization\n Lymph Node Sampling: Sentinel lymph node(s)\n Specimen Laterality: Left\nTumour\n Invasive Carcinoma: Present\n  Histologic Type of Invasive Carcinoma: Invasive ductal carcinoma (no special\n                      type or not otherwise specified)\n  Histologic Grade: Nottingham Histologic Score\n   Glandular (Acinar) / Tubular Differentiation: Score 1: > 75% of tumour area\n                         forming glandular / tubular\n                         structures\n   Nuclear Pleomorphism: Score 2: Cells larger than normal with open vesicular\n              nuclei, visible nucleoli, and moderate variability in\n              both size and shape\n   Mitotic Rate: Score 2 (4-7 mitoses per mm2)\n   Overall Grade: Grade 1: scores of 3, 4 or 5\n Ductal Carcinoma In Situ: DCIS is present\n  Further Classification of DCIS: Negative for extensive intraductal component\n                  (EIC)\nExtent\n Size of Largest Invasive Carcinoma: 12 mm\nMacroscopic and Microscopic Extent of Tumour\nMargins\n Invasive Carcinoma: Margins uninvolved by invasive carcinoma\n  Distance From Closest Margin: 2.2 mm\n  Closest Uninvolved Margin: Inferior\n Ductal Carcinoma In Situ (DCIS): Margins uninvolved by DCIS (DCIS present)\n  Specify Distance of DCIS From Closest Margin: 4.1 mm\n  Closest Uninvolved Margin: Anterior\nAccessory Findings\n Lymph-Vascular Invasion: Not identified\nLymph Nodes\n Sentinel and Non-Sentinel Nodes\n  Total Number of Lymph Nodes Examined (sentinel and nonsentinel): 2\n  Micro / Macro Metastases: Not identified\n   Number of Lymph Nodes With Isolated Tumour Cells (<= 0.2 mm and <= 200 cells): 1\n  Sentinel Nodes: Sentinel lymph node biopsy performed\n   Number of Sentinel Lymph Nodes Examined: 2\n   Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and eosin (H&E),\n                         one level\nStage (pTNM)\n Primary Tumour (pT): pT1c: Tumour > 10 mm but <= 20 mm in greatest dimension\n Regional Lymph Nodes (pN): pN0 (i+): Malignant cells in regional lymph node(s) no\n               greater than 0.2 mm and no more than 200 cells\n               (detected by H&E or IHC including ITC)\n     END SECTION: Breast Invasive Carcinoma : 1\n\n\nPath report.relevant Hx\n\nA.  CA LEFT BREAST, CANCER 1 O'CLOCK LEFT, WIRES LATERAL, LONG STITCH ANTERIOR, SHORT\n   STITCH SUPERIOR\nB-C. CA LEFT BREAST\n(Cross reference: S16:4000 S13:2468 S04:12991)\n\n\nPath report.final diagnosis\n\nA.  Left breast wire localized excision\n     - invasive ductal carcinoma;\n        - grade I;\n        - pT1cN0(i+), see synoptic report;\n        - biomarkers pending.\nB.  Sentinel lymph node #1\n     - single lymph node involved by isolated tumour cells;\n   Sentinel lymph node #2\n     - negative for metastatic adenocarcinoma (0/1);\n     - diagnostic accuracy limited by cautery artefact.\n\n\nPath report.site of origin\n\nA. LEFT BREAST, NOS LEFT BREAST LUMPECTOMY - OUT OF BODY AT 1154\nB. LYMPH NODE, NOS SENTINEL LYMPH NODE #1 HOT AND BLUE\nC. LYMPH NODE, NOS SENTINEL LYMPH NODE #2 HOT\n\n\n"
}